From transfer to transition: review and proposition of the SFNDT dialysis Commission

IF 0.7 4区 医学 Q4 UROLOGY & NEPHROLOGY Nephrologie & Therapeutique Pub Date : 2023-06-19 DOI:10.1684/ndt.2023.17
Annabel Boyer, Antoine Lanot, Bruno Legendre, Anne-Lorraine Clause, Nadia Kabbali, Thierry Lobbedez, Clémence Bechade
{"title":"From transfer to transition: review and proposition of the SFNDT dialysis Commission","authors":"Annabel Boyer,&nbsp;Antoine Lanot,&nbsp;Bruno Legendre,&nbsp;Anne-Lorraine Clause,&nbsp;Nadia Kabbali,&nbsp;Thierry Lobbedez,&nbsp;Clémence Bechade","doi":"10.1684/ndt.2023.17","DOIUrl":null,"url":null,"abstract":"<p><p>Over the course of their disease, patients with chronic kidney disease (CKD) will be treated by several kidney replacement therapy (KRT) modalities. The transitions between KRT modalities can be experienced as traumatic by patients, and are associated with an increased morbidity and mortality, notably when they are not anticipated. Planning these transition phases could reduce the psychological trauma induced by the transfer, as well as reduce the risk of morbidity and mortality. However, the lack of a clear definition of a transfer, and the lack of criteria enabling the identification of patients at risk of transfer, prevents the anticipation of these transition phases at high risk for patients. We here discuss the various possible causes and risk factors of transfer from peritoneal dialysis (PD) to hemodialysis as well as transfer from hemodialysis to PD. The dialysis Commission of the Société francophone de néphrologie, dialyse et transplantation (SFNDT) makes some proposals to improve transition phases, such as the identification of patients at risk, specific PD programs for unplanned PD start, transition unit and hybrid therapy.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 3","pages":"215-222"},"PeriodicalIF":0.7000,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrologie & Therapeutique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/ndt.2023.17","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Over the course of their disease, patients with chronic kidney disease (CKD) will be treated by several kidney replacement therapy (KRT) modalities. The transitions between KRT modalities can be experienced as traumatic by patients, and are associated with an increased morbidity and mortality, notably when they are not anticipated. Planning these transition phases could reduce the psychological trauma induced by the transfer, as well as reduce the risk of morbidity and mortality. However, the lack of a clear definition of a transfer, and the lack of criteria enabling the identification of patients at risk of transfer, prevents the anticipation of these transition phases at high risk for patients. We here discuss the various possible causes and risk factors of transfer from peritoneal dialysis (PD) to hemodialysis as well as transfer from hemodialysis to PD. The dialysis Commission of the Société francophone de néphrologie, dialyse et transplantation (SFNDT) makes some proposals to improve transition phases, such as the identification of patients at risk, specific PD programs for unplanned PD start, transition unit and hybrid therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从转移到过渡:SFNDT透析委员会的审查和建议
在他们的疾病过程中,慢性肾脏疾病(CKD)患者将接受几种肾脏替代疗法(KRT)的治疗。KRT模式之间的转变对患者来说可能是创伤性的,并且与发病率和死亡率的增加有关,特别是在没有预料到的情况下。规划这些过渡阶段可以减少转移引起的心理创伤,并降低发病率和死亡率的风险。然而,由于缺乏对转移的明确定义,以及缺乏能够识别有转移风险的患者的标准,阻碍了对患者高风险的这些过渡阶段的预测。我们在这里讨论从腹膜透析(PD)转移到血液透析以及从血液透析转移到PD的各种可能的原因和危险因素。法国社会组织的透析委员会提出了一些改善过渡阶段的建议,如高危患者的识别、计划外PD启动的特定PD方案、过渡单元和混合治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephrologie & Therapeutique
Nephrologie & Therapeutique 医学-泌尿学与肾脏学
CiteScore
0.80
自引率
14.30%
发文量
485
审稿时长
11.9 weeks
期刊介绍: Organe d''expression de la Société de Néphrologie, de la Société Francophone de Dialyse et de la Société de Néphrologie Pédiatrique, Néphrologie et Thérapeutique a pour vocation de publier des textes en français dans le domaine de la Néphrologie, qu''il s''agisse d''actualisation des connaissances, de recommandations de bonne pratique clinique, de publications originales, ou d''informations sur la vie des trois sociétés fondatrices. La variété des thèmes abordés reflète la richesse de la Néphrologie, qu''il s''agisse d''aspects fondamentaux issus de la physiologie, de l''immunologie, de l''anatomo-pathologie, ou de la génétique, ou de sujets de néphrologie clinique, notamment ceux en rapport avec les thérapeutiques néphrologiques, transplantation, hémodialyse et dialyse péritonéale.
期刊最新文献
Posters Posters commentés Communications orales [Biological parameters for assessment and monitoring anemia in hemodialysis patients]. [Arguments for the use of cardiac biomarkers in hemodialysis: natriuretic peptides and troponins].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1